Literature DB >> 30770862

Maternal preeclampsia and respiratory outcomes in extremely premature infants.

Thea Tagliaferro1, Deepak Jain1, Silvia Vanbuskirk1, Eduardo Bancalari1, Nelson Claure2.   

Abstract

BACKGROUND: Preeclampsia (PE) is a pregnancy complication characterized by an anti-angiogenic environment. This can affect fetal pulmonary vascular and alveolar development but data of the impact of PE on respiratory outcome in extremely premature infants are inconclusive. The objective of this study was to determine if PE is associated with an increased risk for severe respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD) in extremely premature infants.
METHODS: Prospectively collected single center data from a cohort of infants born at 23-28 w gestational age between January 2005 and December 2015 were analyzed. Logistic regression analysis and generalized estimating equations were used to model the association between PE and severe RDS (≥30% supplemental oxygen on d1), BPD and severe BPD [supplemental oxygen and ≥30% oxygen at 36 w postmenstrual age (PMA), respectively].
RESULTS: The cohort included 1218 infants of whom 23% were exposed to PE. PE was associated with increased risk for severe RDS as well as severe BPD among infants alive at 36w PMA.
CONCLUSION: Exposure to preeclampsia is independently associated with an increased risk for severe RDS and adverse respiratory outcome in extreme premature infants. The mechanisms behind these associations need to be investigated.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30770862     DOI: 10.1038/s41390-019-0336-5

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Antenatal Mesenchymal Stromal Cell Extracellular Vesicle Therapy Prevents Preeclamptic Lung Injury in Mice.

Authors:  Elizabeth S Taglauer; Angeles Fernandez-Gonzalez; Gareth R Willis; Monica Reis; Vincent Yeung; Xianlan Liu; Lawrence S Prince; S Alex Mitsialis; Stella Kourembanas
Journal:  Am J Respir Cell Mol Biol       Date:  2022-01       Impact factor: 7.748

2.  Association of Maternal Hypertensive Disorders During Pregnancy With Severe Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis.

Authors:  Gina Lim; Yoo Jinie Kim; Sochung Chung; Yong Mean Park; Kyo Sun Kim; Hye Won Park
Journal:  J Korean Med Sci       Date:  2022-04-25       Impact factor: 5.354

3.  Increased Risk for Respiratory Complications in Male Extremely Preterm Infants: A Propensity Score Matching Study.

Authors:  Zhiwen Su; Lili Lin; Xi Fan; Chunhong Jia; Bijun Shi; Xiaoxia Huang; Jianwei Wei; Qiliang Cui; Fan Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-12       Impact factor: 6.055

4.  The Utility of Comprehensive Metabolic Panel Tests for the Prediction of Bronchopulmonary Dysplasia in Extremely Premature Infants.

Authors:  Xueyu Chen; Binchun Lin; Xiaoyun Xiong; Panpan Sun; Yanqing Kong; Chuanzhong Yang
Journal:  Dis Markers       Date:  2019-10-20       Impact factor: 3.434

5.  Adverse Neonatal Outcome of Pregnancies Complicated by Preeclampsia.

Authors:  Piotr Tousty; Magda Fraszczyk-Tousty; Joanna Ksel-Hryciów; Beata Łoniewska; Joanna Tousty; Sylwia Dzidek; Kaja Michalczyk; Ewa Kwiatkowska; Aneta Cymbaluk-Płoska; Andrzej Torbé; Sebastian Kwiatkowski
Journal:  Biomedicines       Date:  2022-08-22

6.  Mothers with hypertensive disorders of pregnancy increased risk of periventricular leukomalacia in extremely preterm or extremely low birth weight infants: A propensity score analysis.

Authors:  Zhiwen Su; Weiliang Huang; Qiong Meng; Chunhong Jia; Bijun Shi; Xi Fan; Qiliang Cui; Jingsi Chen; Fan Wu
Journal:  Front Pediatr       Date:  2022-08-23       Impact factor: 3.569

7.  Early Preeclampsia Effect on Preterm Newborns Outcome.

Authors:  Melinda Matyas; Monica Hasmasanu; Ciprian N Silaghi; Gabriel Samasca; Iulia Lupan; Kovacs Orsolya; Gabriela Zaharie
Journal:  J Clin Med       Date:  2022-01-17       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.